Humus Capital Partners’ most common sector for investment islife science (100%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (100%).
Sign-up to view Humus Capital Partners’ full profile and discover more small private equity firm investors just like it.
Cerviño 4417, Buenos Aires,,
Buenos Aires,
1425, AR
Argentina
www.humuscapital.com
info@humuscapital.com
| Status | Dates | Company | Description | |
|---|---|---|---|---|
| Investment | Exit | |||
| Current | 2018-06-07 | - |
Biosidus
Life Science Buenos Aires, Argentina www.biosidus.com.ar |
Biosidus is a manufacturer and distributor of biosimilar pharmaceuticals with exports worldwide to more than 25 countries across four continents. The Company's efforts are mainly focused on accelerating the arrival to the market of our pipeline as well as developing innovative technologies such as gene therapy applied to vascular pathology at the central or peripheral level and Transgenic Animals, a technological platform applied to human proteins and functional foods. Biosidus was founded in 1983 and is based in Buenos Aires, Argentina. |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
